We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Search results (4)

« Back to Publications

HPS-4/TIMI 65/ORION-4: A double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease: Trial design, recruitment, and baseline characteristics.

Mafham M. et al, (2026), Am Heart J

Clinical trial results in context: comparison of baseline characteristics and outcomes of 38,510 RECOVERY trial participants versus a reference population of 346,271 people hospitalised with COVID-19 in England.

Pessoa-Amorim G. et al, (2024), Trials, 25

Mission Impossible! Retaining old randomised clinical trial data: the ISIS-2 Legacy Database experience

NUNN M., (2022)

Weight loss in a cardiovascular trial population identifies people at future risk of dementia.

van der Veere P. et al, (2022), Alzheimers Dement (Amst), 14